What Percentage of Americans Are on GLP-1
An estimated 6% to 9% of U.S. adults have used a GLP-1 receptor agonist, with semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) driving most adoption. Prevalenc...
Read article